First case of COVID-19 in a kidney transplant recipient treated with belatacept.
作者信息
Marx David, Moulin Bruno, Fafi-Kremer Samira, Benotmane Ilies, Gautier Gabriela, Perrin Peggy, Caillard Sophie
机构信息
Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Department of Virology, Strasbourg University Hospital, Strasbourg, France.
出版信息
Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919. Epub 2020 Apr 28.
Abstract
摘要
相似文献
1
First case of COVID-19 in a kidney transplant recipient treated with belatacept.接受贝拉西普治疗的肾移植受者中首例新冠肺炎病例。
Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919. Epub 2020 Apr 28.
2
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.肾移植受者新型冠状病毒（SARS-CoV-2）感染：病例报告。
Am J Transplant. 2020 Jul;20(7):1864-1868. doi: 10.1111/ajt.15897. Epub 2020 May 8.
3
COVID-19 in kidney transplant recipients.肾移植受者中的新型冠状病毒肺炎
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
4
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.肾移植受者长期免疫抑制后 COVID-19 肺炎的成功康复。
Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31.
5
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
6
Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient.肝移植受者严重 COVID-19 肺炎的成功治疗。
Am J Transplant. 2020 Jul;20(7):1891-1895. doi: 10.1111/ajt.15901. Epub 2020 Apr 19.
7
SARS Cov-2 infection in a renal-transplanted patient: A case report.肾移植患者感染 SARS-CoV-2：一例报告。
Am J Transplant. 2020 Jul;20(7):1882-1884. doi: 10.1111/ajt.15902. Epub 2020 May 10.
8
Novel coronavirus 2019 pneumonia in a kidney transplant recipient.肾移植受者 2019 年新型冠状病毒肺炎。
Am J Transplant. 2020 Sep;20(9):2599-2601. doi: 10.1111/ajt.15999. Epub 2020 Jun 12.
9
COVID-19 in a high-risk dual heart and kidney transplant recipient.高危心脏和肾脏双器官移植受者中的 COVID-19 感染。
Am J Transplant. 2020 Jul;20(7):1911-1915. doi: 10.1111/ajt.15936. Epub 2020 Jun 22.
10
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine.肾移植受者 COVID-19 肺炎成功接受托珠单抗和羟氯喹治疗。
Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935. Epub 2020 May 13.
引用本文的文献
1
Indications and complications associated with centrifuge-based therapeutic plasma exchange - a retrospective review.基于离心机的治疗性血浆置换的适应症及并发症——一项回顾性研究
BMC Nephrol. 2025 Feb 19;26(1):87. doi: 10.1186/s12882-025-03970-2.
2
A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation.一项新的随机对照试验：肺移植后基于贝利尤单抗的免疫抑制方案。
Transplantation. 2024 Mar 1;108(3):777-786. doi: 10.1097/TP.0000000000004841. Epub 2024 Feb 20.
3
[COVID-19 in transplant recipients: Multicentric report of Mexican experience].[移植受者中的新型冠状病毒肺炎：墨西哥经验的多中心报告]
Arch Cardiol Mex. 2023 Sep 5;93(Supl 6):66-74. doi: 10.24875/ACM.21000113.
4
Covid-19 in kidney transplant recipients with immunosuppressive therapy.接受免疫抑制治疗的肾移植受者中的新冠病毒 19 感染情况。
Caspian J Intern Med. 2022;13(Suppl 3):161-172. doi: 10.22088/cjim.12.4.509.
5
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients.肾移植受者的免疫抑制与新冠病毒感染
Transplant Direct. 2022 Feb 10;8(3):e1292. doi: 10.1097/TXD.0000000000001292. eCollection 2022 Mar.
6
The Role of HLA Antigens and Steroid Dose on the Course of COVID-19 of Patients After Kidney Transplantation.HLA抗原和类固醇剂量对肾移植术后COVID-19患者病程的影响
Front Med (Lausanne). 2021 Nov 1;8:730156. doi: 10.3389/fmed.2021.730156. eCollection 2021.
7
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response.肾移植后使用贝拉西普及其对感染风险和新冠疫苗反应的影响。
J Clin Med. 2021 Nov 3;10(21):5159. doi: 10.3390/jcm10215159.
8
Renal involvement in COVID-19: focus on kidney transplant sector.COVID-19 中的肾脏受累：重点关注肾移植领域。
Infection. 2021 Dec;49(6):1265-1275. doi: 10.1007/s15010-021-01706-6. Epub 2021 Oct 5.
9
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展：2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
10
Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series.2019 年冠状病毒病在心脏移植受者中的结局：单中心病例系列。
J Med Case Rep. 2021 Sep 13;15(1):453. doi: 10.1186/s13256-021-03028-5.
本文引用的文献
1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Opportunistic infections after conversion to belatacept in kidney transplantation.肾移植后转换用巴利昔单抗后的机会性感染。
Nephrol Dial Transplant. 2020 Feb 1;35(2):336-345. doi: 10.1093/ndt/gfz255.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.新型中东呼吸综合征冠状病毒致促炎细胞因子延迟产生和固有抗病毒反应受抑制：对发病机制和治疗的影响。
J Gen Virol. 2013 Dec;94(Pt 12):2679-2690. doi: 10.1099/vir.0.055533-0. Epub 2013 Sep 28.
Zotero 插件